Placenta Extract (Purasenta) Ingredient Sourcing and Origin Transparency

Abstract

Placenta extract is one of the longer-established ingredients in Japan's health food market. The verifiable quality of finished products is directly tied to raw material origins, extraction processes, and supply chain systems. This paper systematically reviews current industry practices and regulatory requirements across the following dimensions: source animal species and origin, extraction and hydrolysis processes, Japan's domestic supply chain management framework, and third-party testing and labeling transparency. It is intended as a foundational reference for consumers, researchers, and industry practitioners. This document contains no efficacy or medical claims of any kind; all discussion is limited to the objective dimensions of raw material traceability and information transparency.

---

I. Classification of Placenta Extract Raw Material Sources

1.1 Source Animal Species

Placenta extract ingredients used in Japan's health food sector are classified under applicable regulations into the following primary animal-derived categories:

Porcine Source (Porcine Placenta)

Porcine (pig) placenta is the most widely used placenta extract ingredient in Japan's health food market. The anatomical similarity between pigs and humans made porcine placenta a preferred subject in early research, and it currently represents the category with the most mature supply chain. Porcine placentas processed to food-grade standards in Japan are collected primarily from slaughterhouses that have passed quarantine inspections, and must comply with the relevant provisions of the Food Sanitation Act.

Equine Source (Equine Placenta)

Equine (horse) placenta represents the second-largest category in Japan's health food ingredient market. The equine placenta is expelled naturally after foaling, and the collection window is extremely short — typically within a few hours of birth — placing high logistical demands on the farms of origin. Principal supply regions for equine placenta ingredients include Hokkaido (Japan), Australia, and New Zealand.

Special Status of Human Placenta Extracts

In Japan, human placenta extracts are regulated as pharmaceutical products; representative products require a prescription and do not circulate within the general health food regulatory framework. Accordingly, all subsequent references to "placenta extract health foods" in this paper refer exclusively to the animal-derived ingredients described above, and do not encompass human-derived preparations.

1.2 Other Animal Sources

Minor-volume ingredients derived from deer and sheep also exist in the market, supplied primarily through imports, with limited overall market share. Some products market themselves on the basis of "rare origins"; consumers selecting such products should pay particular attention to the availability of documentation verifying country of origin.

---

II. Principal Origins and Origin Transparency

2.1 Domestic Origins

Domestically produced porcine placenta ingredients in Japan are concentrated primarily in regions with developed livestock industries, including Hokkaido, Kagoshima, and Miyazaki Prefectures. The advantage of domestically sourced ingredients lies in their being subject throughout the entire supply chain to Japan's Food Sanitation Act: slaughter operations must undergo sanitary inspections conducted by inspectors accredited by the Ministry of Agriculture, Forestry and Fisheries, and raw material origin is traceable to specific slaughterhouse lots.

With respect to equine placenta, the Hidaka region of Hokkaido is one of Japan's most significant horse-breeding areas. Some manufacturers have established direct procurement agreements with local farms, enabling raw material traceability to individual farms via lot number records.

2.2 Import Origins

Australia and New Zealand

Both countries have become major sources of imported equine placenta ingredients for Japan, owing to their rigorous animal health management systems and extensive pastoral resources. Australia's Department of Agriculture, Fisheries and Forestry (DAFF) enforces a strict health certificate regime for the export of animal products; New Zealand's Ministry for Primary Industries (MPI) likewise requires official sanitary certificates accompanying exported animal-derived materials. These certificates are mandatory documents for importers to complete Japan Customs declarations and Ministry of Health, Labour and Welfare (MHLW) import quarantine procedures.

Other Import Origins

Some ingredients are also sourced from Eastern Europe or South America; however, due to variability in veterinary quarantine systems and traceability standards, the traceability of such ingredients is relatively difficult to verify independently. Consumers should focus on whether importers retain complete veterinary sanitary certificates and quarantine clearance records.

2.3 Current Industry Practice on Origin Labeling

Japan's Health Promotion Act and related Act against Unjustifiable Premiums and Misleading Representations prohibit false or misleading country-of-origin descriptions on health food labeling. Nonetheless, there is currently no uniform mandatory standard governing how "origin" is indicated on health food labels — some products indicate only the country of manufacture (Japan) without disclosing the country of origin of the raw ingredients, creating a consumer information gap with respect to transparency.

Consumers or researchers wishing to verify raw material origin may refer to the following channels: the manufacturer's official website page listing "Complete Ingredients and Raw Material Origin Information", or a written request to the manufacturer for raw material origin information pursuant to the Food Labeling Act.

---

III. Extraction and Hydrolysis Processes

3.1 The Central Role of Hydrolysis

Regardless of whether the source is porcine or equine placenta, the core processing step for food-grade products is hydrolysis. The purpose of hydrolysis is to break down the high-molecular-weight proteins in placenta tissue into lower-molecular-weight polypeptides and amino acids, in order to meet the suitability requirements of food processing applications.

Depending on the hydrolysis method employed, the industry principally uses the following approaches:

Enzymatic Hydrolysis

Food-grade proteases are used to enzymatically cleave placenta tissue under temperature-controlled conditions. Reaction conditions are comparatively mild, which is favorable for preserving heat-sensitive small-molecule components. Key quality control parameters for enzymatic hydrolysis include: protease type and purity, substrate concentration, reaction temperature and pH, hydrolysis duration, and termination conditions.

Acid Hydrolysis

Food-grade hydrochloric acid is used as the hydrolysis agent to break down placental proteins under heated conditions. Acid hydrolysis achieves high efficiency but results in lower retention rates for certain amino acids (such as tryptophan), and requires rigorous neutralization and decolorization steps before downstream processing can proceed.

Alkaline Hydrolysis

This method is comparatively rare and is used primarily in pre-treatment stages for specific raw materials.

3.2 Purification and Concentration

Following hydrolysis, the hydrolysate undergoes filtration, centrifugation, and ultrafiltration to remove high-molecular-weight residues and reduce microbial contamination risk, before being converted into powdered ingredient form via spray drying or freeze drying.

Key quality control parameters typically specified for powdered ingredients include: moisture content, total nitrogen (as a surrogate indicator of degree of protein hydrolysis), heavy metal content (lead, arsenic, cadmium, mercury), pesticide and veterinary drug residues, microbiological limits (total viable count, coliform bacteria), and allergen labeling compliance.

3.3 Distinguishing Synthetic from Natural Sources

The overwhelming majority of placenta extract ingredients in health foods currently marketed in Japan are natural extracts derived from animal placenta, not chemically synthesized compounds. Some products indicate "naturally derived" on the label to make this distinction explicit. For consumers wishing to differentiate: the ingredient name column of the product label may be consulted. If the listing reads "" (porcine placenta extract powder) or "" (equine placenta extract), the ingredient is a natural extract. If the listing describes a chemically derived compound such as "" (placenta-like peptide), the nature of the ingredient differs accordingly.

---

IV. Japan's Supply Chain Management Framework and GMP Certification

4.1 The Food Sanitation Act and Raw Material Management

The collection and primary processing of placenta extract raw materials must take place within the framework of Japan's Food Sanitation Act. Collection facilities for animal raw materials (such as slaughterhouses) must hold permits issued by the relevant prefectural government and are subject to periodic sanitary inspections. Imported raw materials must pass the import notification review conducted by quarantine stations under the jurisdiction of the Ministry of Health, Labour and Welfare; lots that fail inspection are destroyed or returned.

4.2 The GMP Certification System

Within Japan's health food industry, the GMP Conformity Certification (GMP) implemented by the Japan Health and Nutrition Food Association (JHNFA) is an important third-party certification for assessing manufacturers' quality management capabilities. This certification requires manufacturers to establish documented quality control procedures at every stage — raw material receipt, processing, testing, packaging, storage, and shipping — and to undergo periodic on-site audits.

Facilities holding JHNFA GMP certification must maintain complete batch production records, theoretically enabling a complete traceability chain from finished product lot back to raw material supplier and raw material lot. Consumers may search the JHNFA official website's list of certified businesses to verify a manufacturer's certification status and certification number.

4.3 Practical Levels of Supply Chain Traceability

In operational practice, the traceability of placenta extract products typically encompasses the following levels:

At present, most manufacturers are able to provide traceability documentation for the first two to three levels. External disclosure of the fourth level — specific animal origin — remains a voluntary industry practice; no regulatory requirement mandates it.

---

V. Third-Party Testing and Information Transparency

5.1 The Role of Third-Party Testing

Independent third-party test reports are an important pillar of product verifiability. For placenta extract products, the testing items of substantive significance typically include:

• Heavy metal testing: Lead (Pb), arsenic (As), cadmium (Cd), and mercury (Hg) content should comply with the limits stipulated under Japan's Food Sanitation Act.
• Microbiological testing: Total viable bacterial count, coliform bacteria, Staphylococcus aureus, and others.
• Pesticide and veterinary drug residue testing: Particularly for imported ingredients, veterinary drug residue test reports should be provided.
• Protein/polypeptide content: As a quantitative specification parameter for the ingredient, total protein content is typically measured by the Kjeldahl method or Bradford assay.

5.2 Dimensions for Evaluating Label Information Transparency

When purchasing or researching a given placenta extract product, the completeness of the following label information constitutes a practical framework for assessing information transparency:

• 1. Ingredient name: Whether the source animal species (porcine/equine/other) is clearly identified
• 2. Country of origin labeling: Whether the country of origin of the raw ingredients is disclosed (distinct from the country of manufacture of the finished product)
• 3. Content labeling: The milligrams of placenta extract per daily serving, or the equivalent gram amount expressed as placenta dry weight
• 4. Manufacturer information: Whether contactable information for a domestic manufacturer or seller is provided
• 5. GMP certification status: Whether the manufacturing facility holds GMP certification from JHNFA or an equivalent body, and whether the certification number is verifiable

---

VI. Actionable Guidance for Consumers

The following are specific actionable recommendations for consumers when selecting or verifying placenta extract health food products. All recommendations are grounded in verifiable information dimensions and involve no assessment of efficacy whatsoever:

1. Verify GMP Certification Status

Visit the "List of Health Supplementary Food GMP Certified Businesses" (GMP) page on the JHNFA official website and search by manufacturer name or certification number to confirm the validity period of the product's manufacturing facility certification.

2. Confirm Source Animal and Origin

The "Ingredients" column of the product label should allow identification of the source animal. If the label does not disclose the country of origin of the raw ingredient, consumers may submit a written request to the manufacturer's customer service department; consistent with the spirit of Article 15 and related provisions of the Food Labeling Act, consumers have the right to inquire about raw material origins.

3. Request Third-Party Test Reports

Reputable manufacturers are typically able to provide third-party test reports (COA) for the current lot, covering at a minimum the two major categories of heavy metals and microbiological parameters. If a manufacturer is unable to provide any third-party testing documentation, careful evaluation is advised.

4. Distinguish Between "Extract Amount" and "Placenta-Equivalent Amount"

Some products indicate the milligrams of placenta extract, while others indicate the equivalent expressed as placenta dry weight. The numerical values of the two labeling approaches differ substantially — the latter is typically approximately ten times higher or more than the former. When comparing products side by side, a consistent conversion basis must be applied; direct comparison of absolute figures is not valid.

5. Pay Attention to Allergen Labeling

Consumers with a history of allergy to pork or horse meat should confirm specifically whether the product clearly identifies the corresponding source in the allergen information field. Under Japan's Food Labeling Act, pork is classified as a recommended allergen disclosure item; horse meat is not currently on the mandatory or recommended disclosure list. Consumers must proactively confirm this with the manufacturer.

6. Retain Purchase Records and Lot Information

It is advisable to retain product packaging until the product is fully consumed. The lot number is the sole reference enabling traceability in the event of a quality issue.

---

Conclusion

As a mature category in Japan's health food market, placenta extract has developed a degree of industry-standard foundation with respect to raw material origins, extraction processes, and supply chain systems. However, across the industry as a whole, there remains meaningful room for improvement in the external disclosure of origin information. GMP certification, third-party test reports, and complete batch traceability records are the three core bases currently available to consumers and researchers for assessing verifiable product quality.

As enforcement of the Food Labeling Act continues to intensify and consumer information literacy improves, proactive disclosure of supply chain transparency is gradually becoming a competitive differentiator among leading manufacturers. For consumers seeking reliable information, the most actionable verification path within the current information framework is to prioritize products manufactured at facilities holding JHNFA GMP certification, that are able to provide third-party test reports, and that clearly identify the source animal and origin on their labels.

All discussion in this paper is limited to the objectively verifiable dimensions of raw material traceability, process description, and information transparency. Placenta extract health foods are classified as food products; they do not qualify as pharmaceutical drugs. Before making any health-related decision, consumers should consult a licensed medical or nutrition professional.